BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15780748)

  • 1. A humanized mouse model for a common beta0-thalassemia mutation.
    Jamsai D; Zaibak F; Khongnium W; Vadolas J; Voullaire L; Fowler KJ; Gazeas S; Fucharoen S; Williamson R; Ioannou PA
    Genomics; 2005 Apr; 85(4):453-61. PubMed ID: 15780748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
    Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia.
    Jamsai D; Zaibak F; Vadolas J; Voullaire L; Fowler KJ; Gazeas S; Peters H; Fucharoen S; Williamson R; Ioannou PA
    Genomics; 2006 Sep; 88(3):309-15. PubMed ID: 16631345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgene copy number-dependent rescue of murine beta-globin knockout mice carrying a 183 kb human beta-globin BAC genomic fragment.
    Vadolas J; Wardan H; Bosmans M; Zaibak F; Jamsai D; Voullaire L; Williamson R; Ioannou PA
    Biochim Biophys Acta; 2005 May; 1728(3):150-62. PubMed ID: 15820143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
    Colah R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Surve R; Subramaniam PG; Bondge N; Pujari K; Ghosh K; Mohanty D
    Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA-mediated reduction of alpha-globin results in phenotypic improvements in beta-thalassemic cells.
    Voon HP; Wardan H; Vadolas J
    Haematologica; 2008 Aug; 93(8):1238-42. PubMed ID: 18556409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.
    Morianos I; Siapati EK; Pongas G; Vassilopoulos G
    Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two new beta0-thalassemic mutations: a deletion (-CC) at codon 142 or overlapping codons 142-143, and an insertion (+T) at codon 45 or overlapping codons 44-45/45-46 of the beta-globin gene.
    Lacan P; Aubry M; Couprie N; Francina A
    Hemoglobin; 2007; 31(2):159-65. PubMed ID: 17486497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescued mice with Hb E transgene-developed red cell changes similar to human beta-thalassemia/HbE disease.
    Wannasuphaphol B; Kalpravidh R; Pattanapanyasat K; Ioannau P; Kuypers FA; Fucharoen S; Winichagoon P
    Ann N Y Acad Sci; 2005; 1054():407-16. PubMed ID: 16339689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel frameshift mutation (+G) at codons 15/16 in a beta0 thalassaemia gene results in a significant reduction of beta globin mRNA values.
    Mo QH; Li XR; Li CF; He YL; Xu XM
    J Clin Pathol; 2005 Sep; 58(9):923-6. PubMed ID: 16126871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanized beta-thalassemia mouse model containing the common IVSI-110 splicing mutation.
    Vadolas J; Nefedov M; Wardan H; Mansooriderakshan S; Voullaire L; Jamsai D; Williamson R; Ioannou PA
    J Biol Chem; 2006 Mar; 281(11):7399-405. PubMed ID: 16421096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A rare transcription mutation (-90 C-->T) in a Chinese family with beta-thalassemia].
    Li WJ; Lao XW; Jai SQ; Liang FA; Mo QH; Ma JY; Xu XM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):468-70. PubMed ID: 14669211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene regulation and deregulation: a beta globin perspective.
    Ho PJ; Thein SL
    Blood Rev; 2000 Jun; 14(2):78-93. PubMed ID: 11012251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele-specific transcription of fetal genes in primary erythroid cell cultures from Lepore and deltabeta degrees thalassemia patients.
    Di Marzo R; Acuto S; Calzolari R; Maggio A
    Exp Hematol; 2005 Nov; 33(11):1363-70. PubMed ID: 16263421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death.
    Ye L; Chang JC; Lu R; Kan YW
    Blood Cells Mol Dis; 2008; 41(1):67-72. PubMed ID: 18207438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
    Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
    Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxamide derivatives of short-chain fatty acid have erythropoietic activity and induce gamma gene expression in vivo.
    Cao H; Jung M; Stamatoyannopoulos G
    Exp Hematol; 2005 Dec; 33(12):1443-9. PubMed ID: 16338486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation of -73(A-->T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia.
    Chen XW; Mo QH; Li Q; Zeng R; Xu XM
    Ann Hematol; 2007 Sep; 86(9):653-7. PubMed ID: 17516066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.